Preferences of US adolescents and parents for vaccination against invasive meningococcal disease
Level of protection and risk of mild-to-moderate side effects were the most important vaccine attributes. Adding a pentavalent vaccine alternative increased WTV particularly among adults, individuals who were vaccine-hesitant, and individuals without health insurance.
Authors
- Sebastian Heidenreich (ORCID: https://orcid.org/0000-0002-1909-5770)
- Paula Peyrani (ORCID: https://orcid.org/0000-0001-8958-1734)
- Brett Hauber (ORCID: https://orcid.org/0000-0003-3129-7268)
- Chiara Whichello (ORCID: https://orcid.org/0000-0003-1905-8985)
- Joshua Coulter (ORCID: https://orcid.org/0000-0002-1795-8536)
- Jessica Presa (ORCID: https://orcid.org/0000-0002-8723-8980)
- Nicolas Krucien (ORCID: https://orcid.org/0000-0001-9179-6558)
- Katharina Schley (ORCID: https://orcid.org/0000-0002-0975-4154)
- Joseph C. Cappelleri (ORCID: https://orcid.org/0000-0001-9586-0748)
Institutions
- Pfizer (United States) (US)
- EVRAZ (United Kingdom) (GB)
Publication Details
- Journal
- Vaccine
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1016/j.vaccine.2024.126264
- Citations
- 2
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 1.06
Funders
- Pfizer